反応式
C1CC2(CCN1)OCCO2.COc1cncc(Br)c1>CC(=O)O.CC(=O)O.CC(C)(C)[O-].CC(C)c1cc(C(C)C)c(-c2ccccc2P(C2CCCCC2)C2CCCCC2)c(C(C)C)c1.Cc1ccccc1.[Na+].[Pd]>COc1cncc(N2CCC3(CC2)OCCO3)c1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 100 °C
実験手順
11/05 2011 07:58:54 +0200 A mixture of 3-bromo-5-methoxypyridine (1.5 g, 7.98 mmol), 1,4-dioxa-8-azaspiro[4.5]decane (1.023 ml, 7.98 mmol), palladium(II) acetate (0.107 g, 0.48 mmol) and dicyclohexyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine (0.228 g, 0.48 mmol) in toluene (38.3 ml) and tBuOH (7.65 ml) was evacuated and flashed with N2 several times. Then sodium 2-methylpropan-2-olate (0.920 g, 9.57 mmol) was added and the reaction mixture was heated to 100°C for 2hrs. LCMS showed complete conversion. Reaction mixture had turned black. The reaction mixture was filtered through celite. The celite was washed with DCM. The combined filtrates were concentrated to yield 2.2g of brown oil, which starts to crystalise patially. Crude NMR showed only little unreacted amine (ca. 14%). The crude was purified by flash: The residue was purified by automated flash chromatography on a 100g column. A gradient from 40% to 100% of EA in Hep over 12CV, 100% EA over 6CV was used as mobile phase. The product was collected using the wavelength 254 nm. 1.5g of desired product were obtained as a light yellow oil.
出典と根拠
- ORDレコード
- ord-7ce32a5d4abb4826b07e10a8720e8cf8
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…